544
Views
13
CrossRef citations to date
0
Altmetric
Article

Lesion size on prostate magnetic resonance imaging predicts adverse radical prostatectomy pathology

, , , & ORCID Icon
Pages 111-115 | Received 04 Jul 2017, Accepted 02 Dec 2017, Published online: 01 Jan 2018

References

  • de Rooij M, Hamoen EH, Witjes JA, et al. Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis. Eur Urol. 2016;70:233–245.
  • Ho R, Siddiqui MM, George AK, et al. Preoperative multiparametric magnetic resonance imaging predicts biochemical recurrence in prostate cancer after radical prostatectomy. PLos One. 2016;11:e0157313.
  • Tay KJ, Gupta RT, Brown AF, et al. Defining the incremental utility of prostate multiparametric magnetic resonance imaging at standard and specialized read in predicting extracapsular extension of prostate cancer. Eur Urol. 2016;70:211–213.
  • Morlacco A, Sharma V, Viers BR, et al. The incremental role of magnetic resonance imaging for prostate cancer staging before radical prostatectomy. Eur Urol. 2017;71:701–704.
  • Epstein JI, Egevad L, Amin MB, et al. The 2014 International Society of Urological Pathology (ISUP) consensus confrence on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. 2016;40:244–252.
  • Rosenkrantz AB, Rice SL, Wehrli NE, et al. Association between changes in suspicious prostate lesions on serial MRI examinations and follow-up biopsy results. Clin Imaging. 2015;39:264–269.
  • Rais-Bahrami S, Turkbey B, Rastinehad AR, et al. Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up. Diagn Interv Radiol. 2014;20:293–298.
  • Bryk DJ, Llukani E, Huang WC, et al. Natural history of pathologically benign cancer suspicious regions on multiparametric magnetic resonance imaging following targeted biopsy. J Urol. 2015;194:1234–1240.
  • Lim CS, McInnes MD, Lim RS, et al. Prognostic value of Prostate Imaging and Data Reporting System (PI-RADS) v. 2 assessment categories 4 and 5 compared to histopathological outcomes after radical prostatectomy. J Magn Reson Imaging. 2017;46:257–266.
  • Raskolnikov D, George AK, Rais-Bahrami S, et al. The role of magnetic resonance image guided prostate biopsy in stratifying men for risk of extracapsular extension at radical prostatectomy. J Urol. 2015;194:105–111.
  • Priester A, Natarajan S, Khoshnoodi P, et al. Magnetic resonance imaging underestimation of prostate cancer geometry: use of patient specific molds to correlate images with whole mount pathology. J Urol. 2017;197:320–326.
  • Krishna S, Lim CS, McInnes MD, et al. Evaluation of MRI for diagnosis of extraprostatic extension in prostate cancer. J Magn Reson Imaging. 2018;47:176–185.
  • Lee DH, Koo KC, Lee SH, et al. Tumor lesion diameter on diffusion weighted magnetic resonance imaging could help predict insignificant prostate cancer in patients eligible for active surveillance: preliminary analysis. J Urol. 2013;190:1213–1217.
  • Rosenkrantz AB, Ream JM, Nolan P, et al. Prostate cancer: utility of whole-lesion apparent diffusion coefficient metrics for prediction of biochemical recurrence after radical prostatectomy. AJR Am J Roentgenol. 2015;205:1208–1214.
  • Schieda N, Lim CS, Idris M, et al. MRI assessment of pathological stage and surgical margins in anterior prostate cancer (APC) using subjective and quantitative analysis. J Magn Reson Imaging. 2017;45:1296–1303.
  • van den Bergh RC, Roemeling S, Roobol MJ, et al. Prospective validation of active surveillance in prostate cancer: the PRIAS study. Eur Urol. 2007;52:1560–1563.
  • Renard Penna R, Cancel-Tassin G, Comperat E, et al. Apparent diffusion coefficient value is a strong predictor of unsuspected aggressiveness of prostate cancer before radical prostatectomy. World J Urol. 2016;34:1389–1395.
  • Baco E, Rud E, Vlatkovic L, et al. Predictive value of magnetic resonance imaging determined tumor contact length for extracapsular extension of prostate cancer. J Urol. 2015;193:466–472.
  • Weinreb JC, Barentsz JO, Choyke PL, et al. PI-RADS prostate imaging – reporting and data system: 2015, Version 2. Eur Urol. 2016;69:16–40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.